![schizophrenia](https://www.adcreviews.com/wp-content/uploads/2022/11/schizophrenia-240x160.jpg)
FDA rejects NDA for Minerva to treat negative symptoms of schizophrenia
Minerva Neurosciences is a biopharmaceutical company focused on developing therapies for diseases of the central nervous system (CNS). Recently, the company announced that it received